Sonoma Pharmaceuticals, Inc. Gains 25.13%

Tue, Nov 01, 2022 at 07:27 PM

Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ) jumped higher at $2.49, representing a gain of 25.1%. On Tue, Nov 01, 2022, SNOA:NASDAQ hit a New 2-Week High of $2.49. The stock got featured on our News Catalysts scanner on Thu, Oct 06, 2022 at 07:32 PM in the 'MISCELLANEOUS' category. From Tue, Oct 18, 2022, the stock recorded 40.00% Up Days and 45.45% Green Days

About Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ)

Sonoma Pharmaceuticals Inc is a speciality pharmaceutical company. It develops,identifies and commercialises therapies for dermatologic diseases.

Top 10 Gainers:

Abiomed, Inc. (ABMD:NASDAQ), 49.88%
Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 46.63%
Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 44%
Ucommune International Ltd (UK:NASDAQ), 34.65%
Safe-T Group Ltd (SFET:NASDAQ), 30.7%
Aravive, Inc. (ARAV:NASDAQ), 30.53%
Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 25.13%
IDEX Biometrics ASA (IDBA:NASDAQ), 23.01%
Harsco Corporation (HSC:NYSE), 22.5%